340 related articles for article (PubMed ID: 24423366)
1. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
J Clin Endocrinol Metab; 2014 Mar; 99(3):1072-80. PubMed ID: 24423366
[TBL] [Abstract][Full Text] [Related]
2. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study.
Norenstedt S; Pernow Y; Brismar K; Sääf M; Ekip A; Granath F; Zedenius J; Nilsson IL
Eur J Endocrinol; 2013 Dec; 169(6):795-804. PubMed ID: 24026893
[TBL] [Abstract][Full Text] [Related]
4. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
Wamberg L; Pedersen SB; Richelsen B; Rejnmark L
Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients.
Björkman M; Sorva A; Risteli J; Tilvis R
Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
8. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
10. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
[TBL] [Abstract][Full Text] [Related]
11. No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
Eur J Endocrinol; 2015 May; 172(5):609-17. PubMed ID: 25646406
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
Macdonald HM; Wood AD; Aucott LS; Black AJ; Fraser WD; Mavroeidi A; Reid DM; Secombes KR; Simpson WG; Thies F
J Bone Miner Res; 2013 Oct; 28(10):2202-13. PubMed ID: 23585346
[TBL] [Abstract][Full Text] [Related]
15. Cholecalciferol Supplementation Promotes Bone Turnover in Chinese Adults with Vitamin D Deficiency.
Yao P; Sun L; Xiong Q; Xu X; Li H; Lin X
J Nutr; 2018 May; 148(5):746-751. PubMed ID: 29897564
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study.
Peacock M; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
J Clin Endocrinol Metab; 2009 Dec; 94(12):4860-7. PubMed ID: 19837909
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
Lima GL; Paupitz JA; Aikawa NE; Alvarenga JC; Pereira RMR
Osteoporos Int; 2018 Mar; 29(3):587-594. PubMed ID: 29152675
[TBL] [Abstract][Full Text] [Related]
20. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design.
Aloia J; Bojadzievski T; Yusupov E; Shahzad G; Pollack S; Mikhail M; Yeh J
J Clin Endocrinol Metab; 2010 Jul; 95(7):3216-24. PubMed ID: 20463100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
